Alumis Inc. Common Stock

ALMSNASDAQ • USD
5.03 USD
↘ 0.57 (10.20%)🟢LIVE (AS OF 01:59 PM EST)
🟢Market: OPEN

Shares of Alumis Inc. Common Stock (ALMS) are trading at $5.03. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ALMS at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$5.59
High?$5.78
Low?$5.02
Prev. Close?$5.60
Volume?1.0M
Avg. Volume?2.0M
VWAP?$5.22
Rel. Volume?0.53x
Bid / Ask
Bid?$5.04 × 100
Ask?$5.05 × 200
Spread?$0.01
Midpoint?$5.05
Valuation & Ratios
Market Cap?727.0M
Shares Out?129.8M
Float?98.3M
Float %?75.9%
P/E Ratio?N/A
P/B Ratio?1.92
EPS?-$3.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Employees
239
Market Cap
727.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-06-28
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
40
Short Sent.?
40
Piotroski F-Score?1/9Weak
Altman Z-Score?-1.66Distress
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.22%High
Short Interest?11.0M
Days to Cover?5.8
Free Float98.3M
Avg Daily Volume1.9M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.57Strong
Quick Ratio?5.57Strong
Cash Ratio?0.73Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
76
1.92CHEAP▾
P/S?
Peers
100
S&P
3
100.43HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
92.46HIGH▾
Returns & Efficiency
ROE?
S&P
3
-111.9%WEAK▾
ROA?
S&P
3
-86.6%WEAK▾
Cash Flow & Enterprise
FCF?$-320925000
Enterprise Value?$669.3M
Fundamentals ratios updated end of day